Mary Jo M. Dales
FDA approvals permit double-immunoassay approach to Lyme disease diagnosis
July 29, 2019
The streamlined approach to diagnosis may speed treatment of Lyme disease.
FDA approves Doptelet for liver disease patients undergoing procedures
May 22, 2018
Avatrombopag (Doptelet) is the first drug approved for thrombocytopenia in adults who have chronic liver disease and are undergoing a procedure.